Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

PCI Biotech Holding Director's Dealing 2019

Aug 29, 2019

3709_dirs_2019-08-29_37a8d9b3-c605-4dba-9730-e043fdf9e828.html

Director's Dealing

Open in viewer

Opens in your device viewer

PCI Biotech: Mandatory notification regarding trade of shares

PCI Biotech: Mandatory notification regarding trade of shares

Borkenholm AS has on 29 August 2019 bought 4,000 shares in PCI Biotech Holding

ASA ("PCI Biotech") at an average price of NOK 26.90 per share. Borkenholm AS is

a related party to board member Hilde Furberg.

After the transaction, Hilde Furberg and her related parties holds 4,000 shares

in PCI Biotech.

This information is subject to the disclosure requirements pursuant to section

4-2 of the Norwegian Securities Trading Act.